SynthesisScientific reports2026
"One Health" perspective on the prevalence of Listeria monocytogenes and its antibiotic resistance profiles in South Africa: a comprehensive systematic review and meta-analysis.
Synthesis in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prevalence and Phenotypic Antimicrobial Resistance ofFoods (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The emergence of Listeria monocytogenes pathogen threatens the era of antimicrobial drugs commonly used in treating listeriosis. This study reviewed the prevalence and antibiotic resistance profiles of L. monocytogenes in South Africa. The random-effect model meta-analysis was used to determine the pooled prevalence estimates (PPE) of L. monocytogenes isolates and their antibiotic resistance (AR) profiles from humans, food and the environmental samples. Original peer reviewed articles published from January 1 1990 to March 23 2024, were searched from PubMed, ScienceDirect, Google Scholar, Scopus, and African Journal Online databases. Comprehensive meta-analysis version 4.0 (CMA) software was used to calculate the PPE. A total of 2,931 samples (n = 1150 from humans, n = 1631 from food, and n = 150 from the environment) derived from 32 articles were incorporated into the meta-analysis. The overall PPE of L. monocytogenes was 73.3%, 33.5% and 44.5%, from human, food, and the environment samples, respectively. The L. monocytogenes serotype 4b-4d-4e had the highest PPE (19.5%). The AR profiles were screened from 1806 L. monocytogenes isolates with the overall multi-drug resistance PPE was 26.3%. The sulII resistance gene, which encodes a drug-resistant dihydropteroate synthase enzyme conferring resistance to sulfonamides, exhibited the highest prevalence of PPE at 47.3%. Among the isolates of L. monocytogenes from South Africa, the inlJ and inlB genes had high PPE values of 83.5% and 80.5%, respectively. These observations clearly demonstrate that L. monocytogenes is pathogen of “One Health” importance, which should not be under estimated. Therefore, a deliberate, concerted effort to formulate joint control and management of this bacteria is required from the human, animal, and environmental health sectors in South Africa.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.